Rose PG, Java JJ, Salani R, Geller MA, Secord AA, Tewari KS, Bender DP, Mutch DG, Friedlander ML, Van Le L, Method MW, Hamilton CA, Lee RB, Wenham RM, Guntupalli SR, Muggia FM, Armstrong DK, Bookman MA, Burger RA, Copeland LJ: Nomogram Predicting Individual Survival Following Recurrence in Advanced Stage High Grade Ovarian Cancer from NRG/GOG Randomized Trials of Platinum and Paclitaxel Obstetrics & Gynecology 133 (2): 245-54,2019.
Nasioudis D, Ko EM, Haggerty AF, Giuntoli II RL, Burger RA, Morgan MA, Latif NA: Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumors Gynecologic Oncology Reports In Press : 2019.
Moore KN, Gunderson C, Sabbatini P, McMeekin DS, Mantia-Smaldone G, Burger R, Morgan MA, Kapoun AM, Brachmann RK, Stagg R, Farooki A, O'Cearbhaill RE: A Phase 1b Dose Escalation Study of Ipafricept (OMP-54F28) in Combination with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer Gynecol Oncol In Press : 2019.
Nasioudis D, Ko E, Haggerty AF, Giuntoli RL II, Burger RA, Morgan RA, Latif N: Isolated distant lymph node metastases in ovarian cancer. Should a new sub-stage be created? Gynecologic Oncology Reports In Press : 2019.
Arend RC, Toboni M, Montgomery AM, Burger RA, Olawaiye AB, Monk BJ, Herzog T.: Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm. The Oncologist 12 : 1533-1545,2018.
Fu S; Corr B; Hamilton E; Burger RA; Wenham R; Naumann RW; Stagg R; Moore KN: A Phase 1b Study of Navicixizumab & Weekly Paclitaxel in Heavily Pre-Treated Platinum Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer. Presented at the European Society for Medical Oncology (ESMO) 2018 Congress, Munich, Germany.
(Abstract) : 2018.
Burger RA, Deng W, Makker V, Collins Y, Gray H Debernardo R, Martin LP, Aghajanian C.: Phase II Evaluation of Dalantercept in the Treatment of Persistent or Recurrent Epithelial Ovarian Cancer: an NRG Oncology/Gynecologic Oncology Group Study Gynecol Oncol 150 (3): 466-470,2018.
Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.: Type of treatment facility impacts survival of patients with ovarian clear cell carcinoma. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.
Nasioudis D; Kanninen T; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.: Residual disease is associated with a worse prognosis in patients with advanced stage sex cord-stromal tumors. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.
Burger RA; Sill M; Zamarin D; Powell D; Frak I; Zivanovic O; Gunderson C; Ko E; Mathews C; Sharma S; Hagemann A; Khleif S; Aghajanian C: NRG Oncology Phase II Randomized Trial of Nivolumab with or without Ipilimumab in Patients with Persistent or Recurrent Ovarian Cancer. Late breaking abstract oral presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.